EcoDrugPlus

Ensembl ID : ENSOJAG00000009273
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSOJAG00000023352
Gene Symbol: RPL10
1 Cross references
408 Possible Orthologues:

Ensembl ID : ENSOJAG00000011693
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOJAG00000010567
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSOJAG00000011526
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOJAG00000011535
Gene Symbol: RPS21
1 Cross references
282 Possible Orthologues:

Ensembl ID : ENSOJAG00000019736
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSOJAG00000019760
Gene Symbol: YES1
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSOJAG00000011542
Gene Symbol: RPS28
1 Cross references
274 Possible Orthologues:

Ensembl ID : ENSOJAG00000021119
Gene Symbol: PRKCI
1 Cross references
87 Possible Orthologues:

Ensembl ID : ENSOJAG00000011572
Gene Symbol: NOTCH1A
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSOJAG00000011138
Gene Symbol: RPL36
1 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).